| Books/Book chapters: |
| 2013 | - 조현병, 마음의 줄을 고르다 (2023년 개정판, 2013년 초판, 군자출판사) |
| 2009 | - Psychiatric Disorders. In "Functional Cerebral SPECT and PET Imaging, 4th edition" (Lippincott Williams & Wilkins, 2009) |
| 2008 | - Molecular Brain Imaging Research in Mental Illness. In "Neurobiology of Mental Illness, 3rd Edition" (Oxford University Press, 2008, 2011) |
| 2006 | - 한국형 정신분열병 약물치료 지침서 2006 (2006년, 대한조현병학회) |
| 2004 | - 비정형 항정신병제의 임상 (2004년 서울대학교 출판부) |
| | Selected Publications: |
| 2024 | - Gwon Y, Kim JH, Lee SW. Quantification of Plasma Dopamine in Depressed Patients Using Silver-Enriched Silicon Nanowires as SERS-Active Substrates. ACS Sensors. 2024 Feb 14. doi: 10.1021/acssensors.3c02202. |
| 2023 | - Kim et al. In Vivo Serotonin 5-HT2A Receptor Availability and Its Relationship with Aggression Traits in Healthy Individuals: A Positron Emission Tomography Study with C-11 MDL100907. Int J Mol Sci. 2023;24(21):15697. doi: 10.3390/ijms242115697 |
| 2023 | - Kim et al. The Relationship between Character Traits and In Vivo Cerebral Serotonin Transporter Availability in Healthy Subjects: A High-Resolution PET Study with C-11 DASB. Pharmaceuticals. 2023;16(5):759. doi: 10.3390/ph16050759. |
| 2023 | - Won et al. Attention Circuits Mediate the Connection between Emotional Experience and Expression within the Emotional Circuit. Clin Psychopharmacol Neurosci. 2023;21(4):715-723. doi: 10.9758/cpn.22.1029 |
| 2023 | - Choi et al. Effects of Flavonoid-Rich Orange Juice Intervention on Major Depressive Disorder in Young Adults: A Randomized Controlled Trial. Nutrients. 2022 Dec 28;15(1):145. doi: 10.3390/nu15010145. |
| 2022 | - Eggerstorfer et al. Meta-analysis of molecular imaging of translocator protein in major depression. Frontiers in Molecular Neuroscience. 2022;15:981442. doi: 10.3389/fnmol.2022. |
| 2022 | - Son et al. Future Prospects of Positron Emission Tomography-Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders. Pharmaceuticals. 2022;15(5):583. doi: 10.3390/ph15050583 |
| 2022 | - Joo et al. In Vivo Cerebral Translocator Protein (TSPO) Binding and Its Relationship with Blood Adiponectin Levels in Treatment-Naïve Young Adults with Major Depression: A [11C]PK11195 PET Study. Biomedicines. 2022;10(1):34. doi: 10.3390/biomedicines10010034 |
| 2022 | - Kim et al. Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment. 2022;18:2041-2053. |
| 2021 | - Choi et al. Deep graph neural network-based prediction of acute suicidal ideation in young adults. Scientific Reports. 2021;11(1):15828. |
| 2021 | - Kim et al. Sex Difference in Peripheral Inflammatory Biomarkers in Drug-Naïve Patients with Major Depression in Young Adulthood. Biomedicines. 2021;9(7):708. |
| 2021 | - Joo et al. Functional analysis of brain imaging suggests changes in the availability of mGluR5 and altered connectivity in the cerebral cortex of long-term abstaining males with alcohol dependence: a preliminary study. Life. 2021;11(6):506. |
| 2021 | - Kim et al. Association between lack of insight and prefrontal serotonin transporter availability in antipsychotic-free patients with schizophrenia: a high-resolution PET study with [11C]DASB. Neuropsychiatr Dis Treat. 2021;17:3195-3203. |
| 2021 | - Vo et al. Ag-deposited porous silicon as a SERS-active substrate for the sensitive detection of catecholamine neurotransmitters. Electronic Materials Letters. 2021;17:292–298. |
| 2020 | - Kim et al. Association between human gray matter metabotropic glutamate receptor-5 availability in vivo and white matter properties: a [11C]ABP688 PET and diffusion tensor imaging study. Brain Struct Funct. 2020;225(6):1805-1816. |
| 2020 | - Joo et al. In vivo glucose metabolism and glutamate levels in mGluR5 knockout mice: a multimodal neuroimaging study using [18F]FDG microPET and MRS. EJNMMI Res. 2020;10(1):116. |
| 2020 | - Kim et al. A Review of Molecular Imaging of Glutamate Receptors. Molecules. 2020 Oct 16;25(20):4749. |
| 2019 | - Kim et al. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naive young adults with major depression. European Neuropsychopharmacology. 2019;29(2):278-290 |
| 2019 | - Kim et al. Relationship of self-transcendence traits with in vivo dopamine D2/3 receptor availability and functional connectivity: An [(18)F]fallypride PET and fMRI study. Synapse. 2019 Nov;73(11):e22121. doi: 10.1002/syn.22121. |
| 2018 | - Phung et al. Reliable and quantitative SERS detection of dopamine levels in human blood plasma using a plasmonic Au/Ag nanocluster substrate. Nanoscale. 2018 Dec;10(47):22493-22503 |
| 2018 | - Kim et al. Penalized PET reconstruction using deep learning prior and local linear fitting. IEEE Transactions on Medical Imaging. 2018 ;37(6):1478-1487 |
| 2018 | - Kim et al. Altered connectivity between striatal and extrastriatal regions in patients with schizophrenia on maintenance antipsychotics: an [18F]fallypride PET and functional MRI study. Synapse. 2018 Dec;72(12):e22064. doi: 10.1002/syn.22064. |
| 2018 | - Kim et al. Neural signature for auditory hallucinations in schizophrenia: a high-resolution positron emission tomography study with fludeoxyglucose (18F). Clin Psychopharmacol Neurosci. 2018;16(3):324-332 |
| 2018 | - Phung et al. Gold nanostructures electrodeposited on graphene oxide-modified indium tin oxide glass as a surface-enhanced Raman scattering-active substrate for ultrasensitive detection of dopamine neurotransmitter. Japanese Journal of Applied Physics 2018;57:08PF02 |
| 2018 | - Joo YH et al. The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: A high-resolution PET study with [18F]fallypride. European Archives of Psychiatry and Clinical Neuroscience 2018 Sep;268(6):529-540. |
| 2017 | - Kim JH et al. Body and liver fat content and adipokines in schizophrenia: a magnetic resonance imaging and spectroscopy study. Psychopharmacology (Berl). 2017 Jun;234(12):1923-1932. |
| 2017 | - Kim JH et al. Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: A high-resolution PET study using [11C]DASB and [18F]FDG. Schizophrenia Research 2017 Apr;182:55-65. |
| 2017 | - Lee et al. Prevalence of metabolic syndrome in patients with schizophrenia in Korea: a multicenter nationwide cross-sectional study. Psychiatry Investig. 2017; 14(1):44-50 |
| 2016 | - Shin Y et al. Self-perceived cognitive deficits and their relationship with internalized stigma and quality of life in patients with schizophrenia. Neuropsychiatr Dis Treat. 2016;12:1411-1417. |
| 2016 | - Kinoshita et al. Efficacy and safety of asenapine in Asian patients with an acute exacerbation of schizophrenia: a multicentre, randomized, double-blind, 6-week, placebo-controlled study. Psychopharmacology (Berl). 2016;233(14):2663-2674 |
| 2016 | - Kim et al. Diminished autonomic neurocardiac function in patients with generalized anxiety disorder. Neuropsychiatr Dis Treat. 2016;12:3111-3118. |
| 2016 | - Kang NI et al. Efficacy and tolerability of paliperidone extended-release in the treatment of first-episode psychosis: an eight-week, open-label, multicenter trial. Clin Psychopharmacol Neurosci 2016;14(3):261-269. |
| 2015 | - Kim JH et al. Self-transcendence trait and its relationship with in vivo serotonin transporter availability in brainstem raphe nuclei: an ultra-high resolution PET-MRI study. Brain Research 2015;1629:63-71 |
| 2015 | - Kim JH et al. Relationship between cognitive insight and subjective quality of life in outpatients with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2041-8. |
| 2015 | - Kim JH et al. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET. Psychiatry Research 2015;231:50-57. |
| 2014 | - Son YD et al. Individually differentiated serotonergic raphe nuclei measured with brain PET/MR imaging. Radiology 2014;272(2):541-548. |
| 2014 | - Kim JH et al. Dopamine D(2/3) receptor availability and human cognitive impulsivity: a high-resolution positron emission tomography imaging study with [11C]raclopride. Acta Neuropsychiatrica 2014;26(1):35-42. |
| 2014 | - Kim JH et al. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine. Comprehensive Psychiatry 2014;55(3):708-713 |
| 2014 | - Park JI et al. The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosis. Int Clin Psychopharmacol. 2014;29(2):77-85. |
| 2013 | - Kim JH et al. Effects of clozapine on heart rate dynamics and their relationship with therapeutic response in treatment-resistant schizophrenia. Journal of Clinical Psychopharmacology 2013;33(1):69-73 |
| 2013 | - Kim JH et al. Anomalous subjective experiences in schizophrenia, bipolar disorder, and unipolar depression. Comprehensive Psychiatry 2013;54(5):447-453 |
| 2013 | - Kim JH et al. Relationship of oestrogen receptor status to depressive symptoms and quality of life in breast cancer patients. Acta Neuropsychiatrica 2013;25(5):283-288. |
| 2013 | - Kim JH et al. Altered heart rate dynamics associated with antipsychotic-induced subjective restlessness in patients with schizophrenia. Neuropsychiatr Dis Treat. 2013;9:989-94. |
| 2012 | - Kim JH et al. Evaluation of the factor structure of symptoms in patients with schizophrenia. Psychiatry Research 2012;197(3):285-289 |
| 2012 | - Park HY et al. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: A 12-week, open-label prospective trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012;36:318-323. |
| 2011 | - Kim JH, et al. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C] raclopride. Journal of Clinical Psychopharmacology 2011;31:507-511 |
| 2011 | - Kim JH, et al. Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study. European Neuropsychopharmacology 2011;21(12):885-891 |
| 2011 | - Kim JH, et al. Association of harm avoidance with dopamine D2/3 receptor availability in striatal subdivisions: A high resolution PET study. Biol Psychol 2011;87(1):164-167. |
| 2011 | - Bullich S, et al. Biodistribution and Radiation Dosimetry of the Glycine Transporter-1 Ligand (11)C-GSK931145 Determined from Primate and Human Whole-Body PET. Mol Imaging Biol. 2011;13(4):776-84. |
| 2011 | - Lee JS, et al. Dose pattern and effectiveness of paliperidone extended-release tablets in patients with schizophrenia. Clinical Neuropharmacology 2011;34:186-190. |
| 2011 | - Kim JH. Subjective experiences in schizophrenia. Australian and New Zealand Journal of Psychiatry 2011;45(3):262. https://doi.org/10.3109/00048674.2011.557649 |
| 2011 | - Kim JH, et al. Relationship between heart rate variability and the severity of psychotic symptoms in schizophrenia. Acta Neuropsychiatrica 2011;23(4):161-166 |
| 2011 | - Kim JH, et al. Insight change and its relationship to subjective well-being during acute atypical antipsychotic treatment. J Clin Pharm Ther 2011;36(6):687-694. |
| 2011 | - Kim JH, et al. Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics. J Clin Pharm Ther 2011;36(2):172-178 |
| 2010 | - Lee YW, et al. Subjective well-being in patients with schizophrenia treated with atypical antipsychotics. Clinical Psychopharmacology and Neuroscience 2010;8:130-136 |
| 2010 | - Kim JH, et al. Relationship between subjective experiences and psychopathological dimensions in schizophrenia. Australian and New Zealand Journal of Psychiatry. 2010;44(10):952-957. |
| 2010 | - Kim JH, Byun HJ. The relationship between akathisia and subjective tolerability in patients with schizophrenia. Int J Neurosci 2010;120(7):507-511 |
| 2010 | - Kim JH, et al. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia. Compr Psychiatry 2010;51:165-170 |
| 2010 | - Bae et al. Gender difference in the association between adult attention deficit hyperactivity disorder symptoms and morningness–eveningness. Psychiatry Clin Neurosci. 2010;64:649-51. |
| 2009 | - Kim JH, et al. The pNNx heart rate variability statistics: an application to clozapine-treated subjects. Psychiatry Investigation 2009;6:294-298 |
| 2009 | - Kim JH, et al. Association of adverse drug effects with subjective well-being in patients with schizophrenia receiving stable doses of risperidone. Clinical Neuropharmacology 2009;32(5):250-253 |
| 2009 | - Kim JH, Byun HJ. Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinsonism. Human Psychopharmacology-Clinical and Experimental 2009;24:129-133. |
| 2009 | - Chang JS, et al. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia. Australian and New Zealand Journal of Psychiatry 2009;43:244-251. |
| 2008 | - Kegeles LS, et al. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology 2008:33(13):3111-25 |
| 2008 | - Jeong SH, et al. A 2-year prospective follow-up study of lower urinary tract symptoms in patients treated with clozapine. J Clin Psychopharmacol. 2008;28:618-24. |
| 2008 | - Jung HY, et al. Measuring psychosis proneness in a nonclinical Korean population: is the Peters et al Delusions Inventory useful for assessing high-risk individuals? Compr Psychiatry. 2008;49(2):202-210. |
| 2008 | - Kim JH, Kim SY, Byun HJ. Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia. Parkinsonism and Related Disorders 2008;14(3):239-42. |
| 2007 | - Martinez D, Kim JH, Krystal J, Abi-Dargham A. Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clinics of North America 2007:17(4):539-55. |
| 2007 | - Kim JH, Byun HJ. Association of subjective cognitive dysfunction with akathisia in patients receiving stable doses of risperidone or haloperidol. Journal of Clinical Pharmacy and Therapeutics 2007:32:461-467 |
| 2006 | - Kim JH, Park CY, Lee SJ. Effects of Sun Ginseng on subjective quality of life in cancer patients: A double-blind, placebo-controlled pilot trial. Journal of Clinical Pharmacy and Therapeutics 2006:31(4):331-334 |
| 2006 | - Kim JH, Yi SH, Park KT, Ahn YM, Lee KY, Yang SA, Kim YS. Diminished Neurocardiac Dynamics Associated With Antipsychotic-induced Extrapyramidal Syndrome. European Neuropsychopharmacology 2006:16(6):459-463 |
| 2006 | - Kim JH, Kim SY, Ahn YM, Kim YS. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006:30(2):301-305 |
| 2005 | - Kim JH, Jin YH, Kang UG, Ahn YM, Ha KS, Kim YS. Neuroleptic-induced acute and chronic akathisia: a clinical comparison. Movement Disorders 2005:20(12):1667-1670 |
| 2005 | - Ahn YM, et al. Reduction in hospital stay of chronic schizophrenic patients after long-term clozapine treatment. Int Clin Psychopharmacol. 2005;20(3):157-161. |
| 2005 | - Jung HY, et al. Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia. Human Psychopharmacology-Clinical and Experimental. 2005;20(1):41-45. |
| 2004 | - Kim JH, Cho SY, Byun HJ, Kang UG, Ahn YM, Kim YS. Multidimensional sensory phenomena in antipsychotic-induced akathisia. Journal of Clinical Psychopharmacology. 2004:24(6):618-623. |
| 2004 | - Kim JH, et al. Heart rate dynamics and their relationship to psychotic symptom severity in clozapine-treated schizophrenic subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2004:28(2):371-378 |
| 2003 | - Kim JH, Byun HJ. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects. Clinical Neuropharmacology 2003:26(6):312-316 |
| 2002 | - Kim JH, et al. Subjective emotional experience and cognitive impairment in drug-induced akathisia. Comprehensive Psychiatry 2002:43(6):456-462 |
| 2002 | - Kim JH, et al. Metric characteristics of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS): a practical rating scale for drug-induced movement disorders. Movement Disorders 2002:17(6):1354-1359 |
| | International Editorial Board |
| Australian and New Zealand Journal of Psychiatry (2011-present, SCI IF: 5.084) |
| Journal Reviewer (Ad hoc) |
| Psychopharmacology (Berl): 2015, 2016 |
| PLOS One: 2013 |
| Schizophrenia Research: 2012 |
| Psychiatry Research: 2006, 2012, 2013 |
| BMC Neurology: 2004-2005, 2007 |
| Psychiatry Investigation: 2005-2013 |
| Alzheimer Disease and Associated Disorders: 2010 |
| Acta Neuropsychiatrica: 2011 |
| Clinical Psychopharmacology and Neuroscience: 2013- |
| Clinical Practice and Epidemiology in Mental Health: 2010 |
| Journal of Korean Neuropsychiatric Association (Korean): 2006-2010 |
| Korean Journal of Schizophrenia Research (Korean): 2008-present |
